Form 4 for ACET Adicet Bio, Inc.
Accepted 2024-01-26 00:00:00 ET · period of report 2024-01-24 · accession 0000950170-24-008048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-26 | 2024-01-24 | ACET | Harvey Brian Nicholas | CFO | A - Grant | $0.00 | +26.3K | 99.8K | +36% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $2.40 | -4,320 | 73.5K | -6% | -$10.4K |
| D | 2024-01-26 | 2024-01-24 | ACET | Harvey Brian Nicholas | CFO | A - Grant | $0.00 | +288.0K | 288.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-24 | A | A | 26,300 | $0.00 | 99,800 | D | — | — | (F2) The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance. |
| 2 | Common | Common Stock | 2024-01-24 | F | D | 4,320 | $2.40 | 73,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-24 | A | A | 288,022 | $0.00 | 288,022 | D | $2.40 · — to 2034-01-23 | 288,022 Common Stock | (F3) 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates. |